11,210
Total Claims
$1.2M
Drug Cost
854
Beneficiaries
$1,410
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
0%
Cost per patient vs peers
$1,410 vs $1,411 avg
+16%
Brand preference vs peers
12.3% vs 10.6% avg
Brand vs Generic
88% generic
Brand: 1,359 claims · $977K
Generic: 9,664 claims · $218K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 81 | $105K |
| Fluticasone/Umeclidin/Vilanter | 70 | $99K |
| Apixaban | 72 | $98K |
| Dulaglutide | 36 | $59K |
| Insulin Glargine,hum.Rec.Anlog | 88 | $50K |
| Sitagliptin Phosphate | 32 | $36K |
| Empagliflozin | 26 | $33K |
| Rivaroxaban | 30 | $30K |
| Dapagliflozin Propanediol | 19 | $28K |
| Insulin Glargine,hum.Rec.Anlog | 51 | $26K |
| Fluticasone/Vilanterol | 32 | $22K |
| Insulin Aspart | 19 | $20K |
| Sitagliptin Phos/Metformin Hcl | 11 | $17K |
| Insulin Glargine,hum.Rec.Anlog | 34 | $16K |
| Atorvastatin Calcium | 850 | $15K |
Prescribing Profile
Patient Profile
75
Avg Age
54%
Female
1.85
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data